better organ growth capit disciplin
reiter valuation-bas hold rais pt
ebitda note improv organ revenue growth
better disclosur l-t term view toward consist price
margin verisk seem regain foot follow
custom consolid impact lumpi fi contract acquisit
integr associ margin expans capit disciplin remain
n-t risk view new revenue ebitda est
prior
street
organ revenue growth rightli focu believ investor key
critic acceler metric although nois around n-
ebitda margin manag clear expect organ
revenue growth extend strong result import
driver opinion verisk enjoy better growth across portfolio
balanc perform contribut woodmac argu
allay acquisit perform concern insur benefit
weather verisk also past advers
effect custom consolid result anticip nearli
insur da organ revenue growth least mid-singl expans
 sub-seg
invest temper n-t margin outlook verisk adam spend
acceler aerial imag revenue growth integr acquisit yield
better l-t ebitda margin manag focus organ margin
expans believ stock cap year
report profit probabl short-sight view long
verisk de-emphas acquisit deal tend disrupt co
track record mix consist argu share buyback
opinion construct l-t view leav us alert possibl entri
capit disciplin next noncommitt believ verisk
move away appropri deal done opinion
fit cleanli compani core insur offer wherea
fi larg tam verisk own good asset
compar core insur busi opinion anticip
verisk slow recent pace tuck-in choos return capit
time opportun transform acquisit probabl rise
believ investor embrac strateg financi accret deal
better woodmac argu perform
improv outlook across board
tr target
rais price target
rais price object would trade ebitda
estim object current valuat signific premium
believ deserv rel premium consid competit posit qualiti
asset embedded custom work flow long-term contract strong profit
see limit upsid current valuat better organ revenu growth outlook materi limit
downsid opinion unclear capit alloc plan on-going invest also temper
page
also base price object proprietari analysi project verisk
drive five-year approxim project base
follow assumpt five-year revenu compound-annual-growth-rate margin expand
flat invest capit
base proprietari analysi would command ev/ic multipl
assum investor demand annual equiti return hold impli equiti
valu one year today assum verisk gener annual averag
discount back rate yield addit valu assert
methodolog least support price target
page
total cost revenu
sell gener administr
depreci amort
realiz gain/ loss invest net
provis incom taxes/ benefit
thousand except per-shar
requir disclosur last tab workbook
ebitda report
amort intang
total cost revenu
sell gener administr
oper margin tot revenu
pre-tax margin tot revenu
ebitda margin revenu
free margin tot revenu
total cost revenu
sell gener administr
depreci amort
compani report suntrust robinson humphrey estim
page
thousand except per-shar
cash equival
feder foreign incom tax receiv
state local inom tax reciev
account payabl accru liabil
short-term debt current portion long-term
pension postretir benfit current
fee receiv advanc
compani report suntrust robinson humphrey estim
page
provid data analyt inform profession insur healthcar
mortgag govern risk manag industri compani oper two segment
risk assess decis analyt risk assess segment serv property-casualty
insur industri help defin measur manag risk provid data softwar
inform servic global servic includ data statist servic actuari servic
standard insur polici program underwrit inform rating-integr tool
decis analyt segment provid custom solut help make inform decis
manag asset associ risk predict futur loss price risk detect prevent
fraud quantifi loss
verisk possess one best-differenti secular growth model univers compani
oper two busi segment high-barri risk assess segment faster-grow
decis analyt segment believ share warrant premium valuat due verisk strong
top-lin growth prospect opportun oper margin expans systemat balanc sheet de-
leverag manag commit return sharehold capit
valuat risk
price target would trade estim ebitda
longer term verisk valuat underpin view strong organ revenu growth like
long-term ebitda margin expans substanti entri barrier balanc sheet de-lever
howev near term ebitda margin pressur reinvest lack tangibl
organ revenu growth catalyst limit near term upsid opinion
upsid risk price target includ greater-than-expect acceler insur segment
organ revenu growth woodmac revenu growth may rebound faster forecast
downsid risk price target includ greater-than-expect ebitda margin headwind
driven continu intern invest acquisit integr impair abil acquir
extern data compani product deriv prolong downturn
insur industri disrupt chang mortgag industri vertic market consolid
and/or price pressur inabl develop new value-ad data analyt solut
result reduc demand compani product
andrew jeffrey herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express specif
recommend report
